Author
Listed:
- Dr. Ahmed Kayode Abdul Mumin
(Department of Community Medicine and Primary Care, Federal Medical Centre Idi-Aba, Abeokuta, Ogun State.)
- Dr. Morufat Ogundeyi
(Department of Paediatrics. Federal Medical Centre, Idi-Aba, Abeokuta. Ogun State)
- Dr. Solomon Olorunfemi Olorunsaiye
(Department of Community Medicine and Primary Care, Federal Medical Centre Idi-Aba, Abeokuta, Ogun State.)
- Oluwadamilola Mary Oladunjoye
(Department of Community Health, College of Health Sciences. Obafemi Awolowo University (OAU), Ile-Ife, Osun State. Nigeria)
- Dr. Adediran Saheed Adekunle
(Department of Paediatrics. Federal Medical Centre, Idi-Aba, Abeokuta. Ogun State)
Abstract
Background: Despite significant progress made towards achieving theWHO-2030 target particularly African regions, viral load non-suppression (VLNS) especially among children and adolescent remains a substantial challenge in resource limited countries. The introduction HAART has led to a remarkable decrease in global HIV infections, however, the burden of VLNS persists poses a troubling threat to the achievement of the WHO goal at record time. Objective: This study aims to assess the proportion of virological failure and identify predictors of VLNS among children and adolescents receiving antiretroviral treatment (ART) at the Federal Medical Centre, Abeokuta, Southwest Nigeria. Methods: A retrospective cross-sectional analysis of clinical data from pediatric patients aged 0-19 years who attended the Federal Medical Center Abeokuta between January 2021 and December 2023 was conducted. The study focused on both patients with viral load ≥ 1000 copies/ml and those with viral load suppression (≤1000 copies/ml). Results:The mean age was 15.76 ± 3.12 years and majority 41 (30.4%). In 2021, 19 (14.1%) had unsuppressed viral load (VL ≥ 1000 copies/ml). In 2022, unsuppressed viral load was 12 (8.9%) and in 2023, unsuppressed viral load was 16 (11.9%). Compliance to ART was significantly associated with VLNS (P value-0.025) for year 2021, 2022 and 2023 respectively.A multivariate regression analysis of predictors of Viral Load Un-suppression showed that across the 3-years under review – compliance to ART was a strong predictor of non-suppression. Conclusion: In spite of resources and gained made in HIV interventions in achieving viral load suppression, a substantial population of children and adolescent still remain virally unsuppressed; 2021 [14.1%], 2022 [8.9%] and 2023 [11.9%] respectively. This study showed that efforts to achieve UNAIDS 2030 is achievable if compliance to ART can be sustained [p-value- 0.025].
Suggested Citation
Dr. Ahmed Kayode Abdul Mumin & Dr. Morufat Ogundeyi & Dr. Solomon Olorunfemi Olorunsaiye & Oluwadamilola Mary Oladunjoye & Dr. Adediran Saheed Adekunle, 2025.
"Human Immunodeficiency Viral Treatment in a Tertiary Facility Concerns on Prevalence and Predictors of Viral Load Non Suppression among Children (0-9) and Adolescents (10-19) Attending Clinic, South-W,"
International Journal of Research and Innovation in Applied Science, International Journal of Research and Innovation in Applied Science (IJRIAS), vol. 10(4), pages 391-409, April.
Handle:
RePEc:bjf:journl:v:10:y:2025:i:4:p:391-409
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:bjf:journl:v:10:y:2025:i:4:p:391-409. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Dr. Renu Malsaria (email available below). General contact details of provider: https://rsisinternational.org/journals/ijrias/ .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.